These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 14529448)

  • 1. GnRH agonists and antagonists in cancer therapy.
    Chengalvala MV; Pelletier JC; Kopf GS
    Curr Med Chem Anticancer Agents; 2003 Nov; 3(6):399-410. PubMed ID: 14529448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic uses of gonadotropin-releasing hormone analogs.
    Andreyko JL; Marshall LA; Dumesic DA; Jaffe RB
    Obstet Gynecol Surv; 1987 Jan; 42(1):1-21. PubMed ID: 3543765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone.
    Engel JB; Schally AV
    Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):157-67. PubMed ID: 17237842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-releasing hormone (GnRH) receptors in tumors: a new rationale for the therapeutical application of GnRH analogs in cancer patients?
    Montagnani Marelli M; Moretti RM; Januszkiewicz-Caulier J; Motta M; Limonta P
    Curr Cancer Drug Targets; 2006 May; 6(3):257-69. PubMed ID: 16712461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin-releasing hormone and its receptor in normal and malignant cells.
    Harrison GS; Wierman ME; Nett TM; Glode LM
    Endocr Relat Cancer; 2004 Dec; 11(4):725-48. PubMed ID: 15613448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical consequences of the administration of a GnRH antagonist during the menstrual cycle].
    Gordon K
    J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 2):3S7-10. PubMed ID: 15643677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New developments in the use of peptide gonadotropin-releasing hormone antagonists versus agonists.
    Schultze-Mosgau A; Griesinger G; Altgassen C; von Otte S; Hornung D; Diedrich K
    Expert Opin Investig Drugs; 2005 Sep; 14(9):1085-97. PubMed ID: 16144493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-peptidic GnRH receptor antagonists.
    Armer RE; Smelt KH
    Curr Med Chem; 2004 Nov; 11(22):3017-28. PubMed ID: 15544487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of SKI2670, a novel, orally active, non-peptide GnRH antagonist, on hypothalamic-pituitary-gonadal axis.
    Kim SM; Yoo T; Lee SY; Kim EJ; Lee SM; Lee MH; Han MY; Jung SH; Choi JH; Ryu KH; Kim HT
    Life Sci; 2015 Oct; 139():166-74. PubMed ID: 26321528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role, mechanism of action and application of gonadoliberins in reproductive processes.
    Teplán I
    Acta Biol Hung; 1989; 40(1-2):3-36. PubMed ID: 2561244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of ovulation: comparison between the mechanism of action of steroids and GnRH analogues.
    Bouchard P; Wolf JP; Hajri S
    Hum Reprod; 1988 May; 3(4):503-6. PubMed ID: 3292571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gonadotropin releasing hormone and analogs. Physiology and pharmacology].
    Kiesel L; Runnebaum B
    Gynakol Geburtshilfliche Rundsch; 1992; 32(1):22-30. PubMed ID: 1325231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel peptides in ovarian follicular fluid: implications for contraceptive development.
    Schwartz NB
    Res Front Fertil Regul; 1982 Sep; 2(2):1-11. PubMed ID: 12179632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotropin-releasing hormone and its clinical applications.
    Loucopoulos A; Ferin M
    Obstet Gynecol Annu; 1984; 13():275-88. PubMed ID: 6326010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biology of gonadotropin hormone-releasing hormone: role in the control of tumor growth and progression in humans.
    Limonta P; Moretti RM; Montagnani Marelli M; Motta M
    Front Neuroendocrinol; 2003 Dec; 24(4):279-95. PubMed ID: 14726258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that gonadotropin-releasing hormone II is not a physiological regulator of gonadotropin secretion in mammals.
    Gault PM; Maudsley S; Lincoln GA
    J Neuroendocrinol; 2003 Sep; 15(9):831-9. PubMed ID: 12899677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homologous desensitization of gonadotropin-releasing hormone (GnRH) receptors in the goldfish pituitary: effects of native GnRH peptides and a synthetic GnRH antagonist.
    Habibi HR
    Biol Reprod; 1991 Feb; 44(2):275-83. PubMed ID: 1849024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G protein-coupled receptors of the hypothalamic-pituitary-gonadal axis: a case for Gnrh, LH, FSH, and GPR54 receptor ligands.
    Heitman LH; Ijzerman AP
    Med Res Rev; 2008 Nov; 28(6):975-1011. PubMed ID: 18561294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-mediated targeting of a photosensitizer by its conjugation to gonadotropin-releasing hormone analogues.
    Rahimipour S; Ben-Aroya N; Ziv K; Chen A; Fridkin M; Koch Y
    J Med Chem; 2003 Sep; 46(19):3965-74. PubMed ID: 12954050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress towards the development of non-peptide orally-active gonadotropin-releasing hormone (GnRH) antagonists: therapeutic implications.
    Millar RP; Zhu YF; Chen C; Struthers RS
    Br Med Bull; 2000; 56(3):761-72. PubMed ID: 11255560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.